AGNG

Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 06/16/21

Key Facts

Ticker	AGNG
Inception Date	05/09/16
CUSIP	37954Y772
ISIN	US37954Y7720
Bloomberg Index Ticker	ILNGRNT
Primary Exchange	Nasdaq
Number of Holdings	99

Stats & Fees

Net Assets	$45,953,014
Net Asset Value (NAV)	$30.43
Shares Outstanding	1,510,000
Total Expense Ratio	0.50%

Distributions

30-Day SEC Yield	0.67%
Distribution Frequency	Semi-Annually

Fund Documents

Fund Research

Fund Prices As of 06/16/21

NAV	$30.43	Daily Change	-$0.10	-0.34%
Market Price	$30.39	Daily Change	-$0.21	-0.70%
30-Day Median Bid-Ask Spread	0.27%

As of recent (03/31/21) As of recent (03/31/21)	Fund NAV	Market Price	Index
1 Year	37.23%	37.70%	37.64%
3 Years	12.81%	12.79%	13.07%
Since Inception	13.85%	14.40%	14.16%
1 Year	21.08%	20.93%	21.71%
3 Years	13.66%	13.55%	13.99%
5 Years	14.18%	14.16%	14.55%
Since Inception	14.57%	15.04%	14.94%
Year-to-Date	-1.25%	-0.61%	-1.22%
1 Month	-0.36%	-0.22%	-0.37%
3 Months	-1.25%	-0.61%	-1.22%
Since Inception	88.63%	93.16%	91.25%
Year-to-Date	4.18%	4.55%	4.51%
1 Month	0.76%	0.72%	0.99%
3 Months	5.11%	4.96%	5.40%
Since Inception	98.99%	103.19%	102.34%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 06/16/21

Return on Equity	15.10%
Weighted Avg. Market Cap	76,822 M
	2020	2021
Price-to-earnings	33.01	27.93
Price-to-book value	4.43	4.02

Source: AltaVista Research, LLC

Fund Risk Stats As of 06/16/21

Versus	Beta
S&P 500	0.83
MSCI EAFE	0.79
MSCI Emg. Mkts	0.65
Standard Deviation	18.50%

Source: AltaVista Research, LLC

Sector Breakdown As of 05/31/21

% of Net Assets
	Health Care	93.6
	Real Estate	5.0
	Information Technology	0.7
	Communication Services	0.4
	Industrials	0.3

Source: AltaVista Research, LLC

Country Breakdown As of 05/31/21

% of Net Assets
	United States	56.1
	Switzerland	7.9
	Japan	6.8
	Denmark	6.3
	Britain	5.9
	China	5.9
	Ireland	3.3
	South Korea	1.9
	Germany	1.4
	Belgium	1.3
	France	0.7
	Other/Cash	2.5

Source: AltaVista Research, LLC

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
3.42	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	84.59	18,587	1,572,302.30
3.39	LLY	ELI LILLY & CO	2516152	220.76	7,053	1,557,020.28
3.33	EW	EDWARDS LIFESCIENCES CORP	2567116	100.14	15,296	1,531,741.44
3.32	RO SW	ROCHE HOLDING AG-BR	7108918	413.59	3,689	1,525,746.93
3.31	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	58.41	26,011	1,519,302.51
3.26	BIIB	BIOGEN INC	2455965	391.31	3,832	1,499,499.92
3.10	BSX	BOSTON SCIENTIFIC CORP	2113434	42.78	33,244	1,422,178.32
3.08	REGN	REGENERON PHARMACEUTICALS	2730190	523.58	2,703	1,415,236.74
3.05	ABBV	ABBVIE INC	B92SR70	115.53	12,134	1,401,841.02
3.03	BMY	BRISTOL-MYERS SQUIBB CO	2126335	66.92	20,792	1,391,400.64
2.90	MDT	MEDTRONIC PLC	BTN1Y11	125.02	10,668	1,333,713.36
2.88	4519 JP	CHUGAI PHARMA CO	6196408	41.07	32,209	1,322,694.39
2.88	SYK	STRYKER CORP	2853688	256.40	5,152	1,320,972.80
2.83	JNJ	JOHNSON & JOHNSON	2475833	164.43	7,900	1,298,997.00
2.72	AMGN	AMGEN INC	2023607	239.58	5,212	1,248,690.96
2.14	DXCM	DEXCOM INC	B0796X4	403.75	2,434	982,727.50
1.95	ALC SW	ALCON INC	BJT1GR5	71.37	12,582	898,004.47
1.85	WELL	WELLTOWER INC	BYVYHH4	80.80	10,517	849,773.60
1.83	068270 KS	CELLTRION INC	B0C5YV1	243.01	3,467	842,506.60
1.81	4503 JP	ASTELLAS PHARMA INC	6985383	17.75	46,954	833,423.36
1.81	ZBH	ZIMMER BIOMET HO	2783815	158.03	5,248	829,341.44
1.74	4543 JP	TERUMO CORP	6885074	41.70	19,203	800,816.36
1.68	BGNE	BEIGENE LTD-ADR	BYYWPW6	333.31	2,312	770,612.72
1.57	GMAB DC	GENMAB A/S	4595739	442.76	1,627	720,365.51
1.51	SGEN	SEAGEN INC	BLPK4D2	151.32	4,575	692,289.00
1.37	FME GR	FRESENIUS MEDICA	5129074	84.81	7,404	627,924.52
1.35	STMN SW	STRAUMANN HOLDING AG-REG	7156832	1,557.37	397	618,276.88
1.31	3692 HK	HANSOH PHARMACEU	BJYKB72	4.10	147,000	603,215.81
1.26	SOON SW	SONOVA HOLDING AG-REG	7156036	361.87	1,604	580,434.06
1.22	NVCR	NOVOCURE LTD	BYSS4X4	220.60	2,539	560,103.40
1.14	VTR	VENTAS INC	2927925	57.77	9,102	525,822.54
1.10	EXAS	EXACT SCIENCES CORP	2719951	120.38	4,192	504,632.96
1.08	UCB BB	UCB SA	5596991	103.64	4,805	497,998.67
1.03	SN/ LN	SMITH & NEPHEW PLC	0922320	21.85	21,715	474,548.58
1.02	TFX	TELEFLEX INC	2881407	395.97	1,184	468,828.48
1.00	PODD	INSULET CORP	B1XGNW4	279.49	1,638	457,804.62
0.98	INCY	INCYTE CORP	2471950	83.12	5,430	451,341.60
0.78	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	7.96	44,800	356,419.06
0.74	DEMANT DC	DEMANT A/S	BZ01RF1	57.13	5,961	340,570.29
0.74	ABMD	ABIOMED INC	2003698	303.30	1,120	339,696.00
0.73	DVA	DAVITA INC	2898087	122.78	2,742	336,662.76
0.67	GN DC	GN STORE NORD A/S	4501093	87.08	3,526	307,060.87
0.66	COH AU	COCHLEAR LTD	6211798	186.51	1,621	302,334.27
0.60	AMP IM	AMPLIFON SPA	B14NJ71	48.74	5,607	273,300.05
0.50	NBIX	NEUROCRINE BIOSC	2623911	98.59	2,313	228,038.67
0.48	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	73.61	2,966	218,327.26
0.46	OHI	OMEGA HEALTHCARE	2043274	37.24	5,695	212,081.80
0.45	ORP FP	ORPEA	7339451	129.86	1,590	206,469.73
0.44	UTHR	UNITED THERAPEUTICS CORP	2430412	183.44	1,093	200,499.92
0.43	AMED	AMEDISYS INC	2024332	242.57	810	196,481.70
0.37	FGEN	FIBROGEN INC	BSDRYR8	25.84	6,651	171,861.84
0.37	EXEL	EXELIXIS INC	2576941	22.43	7,660	171,813.80
0.36	1858 HK	BEIJING CHUNLI-H	BVVPXP6	3.29	50,300	165,254.81
0.35	INGN	INOGEN INC	BJSVLL5	66.61	2,389	159,131.29
0.34	BKD	BROOKDALE SR	B0PZN33	8.75	17,968	157,220.00
0.34	ACAD	ACADIA PHARMACEU	2713317	25.90	6,050	156,695.00
0.34	LHCG	LHC GROUP INC	B06DT50	197.56	780	154,096.80
0.33	HALO	HALOZYME THERAPEUTICS INC	2975098	43.10	3,545	152,789.50
0.33	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.60	254,200	151,308.55
0.32	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.66	221,547	147,286.02
0.31	AED BB	AEDIFICA	B1G5XP1	137.19	1,045	143,360.60
0.31	ALEC	ALECTOR INC	BJ4LDC4	22.43	6,363	142,722.09
0.31	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	1.55	91,600	142,327.47
0.31	8086 JP	NIPRO CORP	6641599	12.53	11,346	142,205.54
0.31	BLUE	BLUEBIRD BIO INC	BBFL7S1	32.78	4,332	142,002.96
0.30	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	58.78	2,365	139,014.70
0.30	CSH-U CN	CHARTWELL RETIRE	B8S8C94	10.74	12,785	137,308.32
0.29	EPZM	EPIZYME INC	B9Z1QZ7	8.83	14,849	131,116.67
0.29	ANGO	ANGIODYNAMICS INC	B00CR04	25.33	5,174	131,057.42
0.28	ITGR	INTEGER HOLDINGS CORP	BD06LM7	94.02	1,373	129,089.46
0.28	LIVN	LIVANOVA PLC	BYMT0J1	82.29	1,567	128,948.43
0.28	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	61.70	2,089	128,891.30
0.28	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	14.10	9,133	128,763.73
0.27	TCMD	TACTILE SYSTEMS	BZB1XF2	52.21	2,412	125,930.52
0.27	2500 HK	VENUS MEDTECH -H	BL6V047	8.53	14,700	125,377.98
0.27	MNKD	MANNKIND CORP	BF081J4	4.33	28,952	125,362.16
0.27	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	49.33	2,514	124,015.62
0.27		CASH		1.00	123,695	123,703.36
0.27	NUVA	NUVASIVE INC	B00GJC2	66.61	1,856	123,628.16
0.27	KORI FP	KORIAN	B1HKRM0	37.16	3,303	122,729.18
0.27	NHC	NATIONAL HEALTHCARE CORP	2139731	74.23	1,651	122,553.73
0.27	ARNA	ARENA PHARMACEUTICALS INC	BF3N4P3	64.64	1,883	121,717.12
0.26	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	85.56	1,419	121,409.64
0.26	SBRA	SABRA HEALTH CAR	B5NLBP6	17.86	6,764	120,805.04
0.26	RDUS	RADIUS HEALTH INC	BM68KK1	18.91	6,292	118,981.72
0.26	4547 JP	KISSEI PHARM CO	6494061	20.18	5,880	118,674.97
0.26	GKOS	GLAUKOS CORP	BYMWL19	80.11	1,474	118,082.14
0.25	PNTG	PENNANT GROUP INC/THE	BKTC976	41.00	2,841	116,481.00
0.25	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	84.93	1,350	114,655.50
0.25	HRTX	HERON THERAPEUTICS INC	BJ0XLZ3	15.75	7,244	114,093.00
0.25	RYM NZ	RYMAN HEALTHCARE LTD	6161525	9.32	12,215	113,807.60
0.24	LTC	LTC PROPERTIES INC	2498788	38.99	2,864	111,667.36
0.24	NHI	NATL HEALTH INVESTORS INC	2626125	65.76	1,674	110,082.24
0.23	DHC	DIVERSIFIED HEAL	BKRN595	4.15	25,962	107,742.30
0.23	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	14.88	7,196	107,076.48
0.23	AERI	AERIE PHARMACEUTICALS INC	BFRTDG1	16.12	6,588	106,198.56
0.23	OMER	OMEROS CORP	B4NB858	15.00	7,067	106,005.00
0.23	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	18.28	5,744	105,000.32
0.22	AMRN	AMARIN CORP PLC -ADR	2301938	4.89	20,779	101,609.31
0.22	PHM SM	PHARMA MAR SA	BMW2GT8	93.07	1,079	100,426.83

Holdings are subject to change.

Latest Premium / Discount As of 06/16/21

NAV	$30.43
Market Price	$30.39
Premium / (Discount)	($0.04)

Current View 2021 Q2 As of 06/16/21

Days at Premium	41
Days at NAV	0
Days at Discount	12
Greatest Premium	0.57%
Greatest Discount	-0.23%

Daily Premium / Discount History As of 06/16/21

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Fund Summary

Fund Objective

Why AGNG?

High Growth Potential

Unconstrained Approach

ETF Efficiency

Fund Details As of 06/16/21

Key Facts

Stats & Fees

Distributions

Fund Documents

Fund Research

Fund Prices As of 06/16/21

Performance History

Fund Characteristics As of 06/16/21

Fund Risk Stats As of 06/16/21

Sector Breakdown As of 05/31/21

Country Breakdown As of 05/31/21

Top Holdings As of 06/16/21